HOME >> MEDICINE >> NEWS
From DNA to work and play

The American Psychological Society's 2004 Annual Convention program is online and searchable at http://www.psychologicalscience.org/convention/program/index.cfm.

Psychological scientists conduct cutting-edge research on issues we confront in our everyday lives. What is the role of behavior in health? How do people think, learn, and remember? What's really behind the things we think of as personality, courage, motivation, emotion, deception? How do we negotiate relationships, problems in the workplace, changes in life? Stress, mental disorder, love, memory, aging These and many more of the conditions that define us as individuals are addressed from a variety of perspectives, from neurobiology and psychophysiology to social and organizational science. It all adds up to fascinating insights into ourselves and the world around us.

This research is being presented at the Society's upcoming Annual Convention in Chicago. With the online program you can browse by day, find presenters, and conduct keyword searches on topics most relevant to your audience.

At the APS Annual Convention, you'll find presentations about the latest findings across a wide variety of topics, including:

  • Memory, Consciousness, and Time
  • The New Biological Bases of Behavior
  • Are You A Supertaster? How Can You Tell? What Does It Matter?
  • Quality of Life
  • Is There a Core Deficit in Autism?
  • and more!
  • The meeting will be from May 27-30, 2004 at the Sheraton Chicago Hotel & Towers in Chicago, Illinois. This meeting is open to the media, but a complimentary registration is required for access to meeting spaces. For more information, or if you would like to register (media representatives are entitled to complementary registration for the convention), please contact Brian Weaver at

    Contact: Brian Weaver
    bweaver@psychologicalscience.org
    202-783-2077
    Association for Psychological Science
    19-Apr-2004


    Page: 1 2

    Related medicine news :

    1. Exposure to famine associated with increased breast cancer risk
    2. Exposure to carcinogens not proportionally decreased by reduction in smoking
    3. Exposure to atomic bomb radiation associated with nervous system tumors
    4. Exposure to bacteria modulates immune response and decreases allergy in farm children
    5. Exposure to hepatitis C has no effect on antiretroviral treatment outcomes in HIV patients
    6. Exposure to light and sleep pattern alteration
    7. Near-Sightedness In Children Linked To Light Exposure During Sleep Before Age Two
    8. Repeated Exposure To Cocaine Alters Brain Structure
    9. UB Oral Biologists Find Link Between Gum Disease And Passive Exposure To Tobacco Smoke
    10. Despite Progress, More Action Needed To Protect Medical Students From Exposure To Disease Through Accidental Needlesticks, UCSF Study Finds
    11. Prenatal Cocaine Exposure Leads To Lower Child IQ Scores, Language Skills

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: From DNA work and play

    (Date:5/21/2013)... CA (PRWEB) May 21, 2013 Global ... organization, and Bodybuilding.com, the largest online retailer of health ... a new reality-based sports show, Warrior Island. “We ... on; YouTube, Facebook & Twitter, with our unique social ... Island maroons these elite fighters on an island in ...
    (Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
    (Date:5/21/2013)... or the removal of the adenoids and tonsils, is ... often as a treatment for children with obstructive sleep ... child,s attention and executive functioning, behavior, sleep apnea symptoms, ... until now. A study led by Susan Redline, ... and Cardiovascular Medicine and Associate Clinic Director of the ...
    (Date:5/21/2013)... Go Classy Tours, the oldest and ... redesigned their website featuring N Resort in Jamaica ... bars and dining. The website, which has always featured ... guest reviews, will now have a broader range of ... on culinary local recipes, flora and fauna, featured pictures ...
    (Date:5/21/2013)... 2013 The American Diabetes Association ( ... the United States of America are affected with peripheral ... great risk of developing peripheral neuropathy which unfortunately makes ... ADA further goes on saying that the disease usually ... 2 million new cases are diagnosed every year in ...
    Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2
    (Date:5/21/2013)... , May 21, 2013  Vasomedical, Inc. (OTC BB: VASO) ... design, manufacture and sale of medical devices and in the ... Jun Ma , President and CEO of ... MicroCap Conference on Thursday, May 30, 2013 in ... The Company,s presentation is scheduled to begin ...
    (Date:5/21/2013)... 2013 Reportlinker.com announces that a ... its catalogue:   ... Coherence Tomography (OCT) http://www.reportlinker.com/p01187977/Global-Markets-and-Technologies-for-Optical-Coherence-Tomography-OCT.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...   BCC,s aim ... synopsis of the current and future characteristics ...
    (Date:5/21/2013)... , May 21, 2013  Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...
    Breaking Medicine Technology:Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
    Cached News: